Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek J Richard

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2017
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung CancerMark N Adams, Joshua T Burgess, Yaowu He, et al.
The Journal of Biological Chemistry|July 17, 2009
HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage responseYongjiang Li, Emma Bolderson, Rakesh Kumar, et al.
International Journal of Endocrinology|December 20, 2016
Sex Hormone Binding Globulin Modifies Testosterone Action and Metabolism in Prostate Cancer CellsHuika Li, Thy Pham, Brett C McWhinney, et al.
Proteins|August 24, 2019
The structural details of the interaction of single-stranded DNA binding protein hSSB2 (NABP1/OBFC2A) with UV-damaged DNATeegan Lawson, Serene El-Kamand, Didier Boucher, et al.
Molecular Cancer|January 29, 2020
Correction to: Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancerMartin P Barr, Steven G Gray, Kathy Gately, et al.
British Journal of Cancer|May 23, 2020
Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancerAmila Suraweera, Alex Duff, Mark N Adams, et al.
Molecular Cancer|April 19, 2015
Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancerMartin P Barr, Steven G Gray, Kathy Gately, et al.
Cell Death & Disease|November 11, 2016
Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic responseJoshua T Burgess, Emma Bolderson, Mark N Adams, et al.
British Journal of Cancer|January 27, 2021
Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancerAmila Suraweera, Alex Duff, Mark N Adams, et al.
Scientific Reports|October 30, 2020
SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancerJoshua T Burgess, Emma Bolderson, Mark N Adams, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2017
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung CancerMark N Adams, Joshua T Burgess, Yaowu He, et al.
The Journal of Biological Chemistry|July 17, 2009
HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage responseYongjiang Li, Emma Bolderson, Rakesh Kumar, et al.
International Journal of Endocrinology|December 20, 2016
Sex Hormone Binding Globulin Modifies Testosterone Action and Metabolism in Prostate Cancer CellsHuika Li, Thy Pham, Brett C McWhinney, et al.
Proteins|August 24, 2019
The structural details of the interaction of single-stranded DNA binding protein hSSB2 (NABP1/OBFC2A) with UV-damaged DNATeegan Lawson, Serene El-Kamand, Didier Boucher, et al.
Molecular Cancer|January 29, 2020
Correction to: Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancerMartin P Barr, Steven G Gray, Kathy Gately, et al.
British Journal of Cancer|May 23, 2020
Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancerAmila Suraweera, Alex Duff, Mark N Adams, et al.
Molecular Cancer|April 19, 2015
Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancerMartin P Barr, Steven G Gray, Kathy Gately, et al.
Cell Death & Disease|November 11, 2016
Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic responseJoshua T Burgess, Emma Bolderson, Mark N Adams, et al.
British Journal of Cancer|January 27, 2021
Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancerAmila Suraweera, Alex Duff, Mark N Adams, et al.
Scientific Reports|October 30, 2020
SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancerJoshua T Burgess, Emma Bolderson, Mark N Adams, et al.
Pageof 11